InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,711.92
(
0.06%
)
US TECH 100
19,314.00
(
0.33%
)
Dow Jones
42,197.37
(
0.10%
)
Brent Oil
74.39
(
-0.05%
)
Bitcoin
61,170.29
(
0.56%
)
Post# of 253265
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: bladerunner1717 post# 213609

Tuesday, 09/12/2017 9:04:27 PM

Tuesday, September 12, 2017 9:04:27 PM

Post# of 253265

Will TRIL be at ASH this year?

Not sure on that. Per the 2Q17 results (http://trilliumtherapeutics.com/investors/news/Press-Release-Details/2017/Trillium-Therapeutics-Reports-Second-Quarter-2017-Financial-And-Operating-Results/default.aspx ), here are the clinical events expected 2H of this year:

"Preliminary data from the TTI-621 Phase 1a intratumoral dose escalation trial in solid tumors
Additional clinical data from the TTI-621 Phase 1b intravenous trial
IND submission for TTI-622, the Company’s IgG4 SIRPaFc protein that is primarily being developed for combination therapies"

I'm guessing some of that data could be presented at ASH.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up